Cutler Group LP Invitae Corp Put Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 01, 2023	SELL	$1.2 - $2.73 $8,040 - $18,291	-6,700 Reduced 97.1%	200 $2,000
Q4 2022 Feb 07, 2023	SELL	$1.71 - $3.61 $23,598 - $49,818	-13,800 Reduced 66.67%	6,900 $55,000
Q3 2022 Oct 25, 2022	BUY	$1.9 - $8.63 $22,040 - $100,108	11,600 Added 127.47%	20,700 $72,000
Q2 2022 Aug 04, 2022	SELL	$2.13 - $9.01 $15,123 - $63,971	-7,100 Reduced 43.83%	9,100 $81,000
Q1 2022 Apr 14, 2022	SELL	$6.28 - $15.59 $341,004 - $846,537	-54,300 Reduced 77.02%	16,200 $124,000
Q4 2021 Jan 18, 2022	BUY	$14.7 - $28.67 $486,570 - $948,977	33,100 Added 88.5%	70,500 $738,000
Q3 2021 Oct 26, 2021	BUY	$24.31 - $33.6 $386,529 - $534,240	15,900 Added 73.95%	37,400 $138,000
Q2 2021 Jul 19, 2021	SELL	$26.09 - $40.4 $232,201 - $359,560	-8,900 Reduced 29.28%	21,500 $94,000
Q1 2021 Apr 26, 2021	BUY	$33.06 - $56.93 $1 Million - $1.72 Million	30,300 Added 30300.0%	30,400 $108,000
Q3 2017 Oct 17, 2017	BUY	$8.89 - $10.4 $889 - $1,040	100	100 $0

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.